Cited by 135GDF15 and Related BiomarkersIron Metabolism and DisordersHemoglobinopathies and Related Disorders

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I

Open access
Tamary, Hannah, Shalev, Hanna, Perez-Avraham, Galit, Zoldan, Meira, Levi, Itai, Swinkels, Dorine W., Tanno, Toshihiko, Miller, Jeffery L.·2008·Blood

Abstract

Congenital dyserythropoietic anemia (CDA) is a rare group of red blood cell disorders characterized by ineffective erythropoiesis and increased iron absorption. To determine whether growth differentation factor 15 (GDF15) hyper-expression is associated with the ineffective erythropoiesis and iron-loading complications of CDA type I (CDA I), GDF15 levels and other markers of erythropoiesis and iron overload were studied in blood from 17 CDA I patients. Significantly higher levels of GDF15 were detected among the CDA I patients (10 239 +/- 3049 pg/mL) compared with healthy volunteers (269 +/- 238 pg/mL). In addition, GDF15 correlated significantly with several erythropoietic and iron parameters including Hepcidin-25, Ferritin, and Hepcidin-25/Ferritin ratios. These novel results suggest that CDA I patients express very high levels of serum GDF15, and that GDF15 contributes to the inappropriate suppression of hepcidin with subsequent secondary hemochromatosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2008-06-165738

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased GDF15 serum levels associate with syndromes of ineffective erythropoiesis, for example α- and β-thalassemia.

    “While increased GDF15 serum levels associate with syndromes of ineffective erythropoiesis, for example α- and β-thalassemia”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [218]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tamary, H., Shalev, H., Perez-Avraham, G., Zoldan, M., Levi, I., Swinkels, D. W., Tanno, T., & Miller, J. L.
Affiliations
  • Tel Aviv University (IL)
  • Ben-Gurion University of the Negev (IL)
  • Hematology Soroka Medical Center, Faculty of Medicine, Ben-Gurion University, Beer Sheva, Israel;
  • Radboud University Nijmegen (NL)
  • National Institutes of Health (US)
Venue
Blood
Published
2008-12-15
Volume
112
Issue
13
Pages
5241-5244
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2090925999
Cited by
135
References
16
Citations by year
2025: 3 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 13 · 2012: 16
FWCI
10.16
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Health Sciences › Medicine › Rheumatology › GDF15 and Related Biomarkers
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
Keywords
growth differentiation factor 15, congenital dyserythropoietic anemia type I, ineffective erythropoiesis, iron overload, hepcidin, ferritin, secondary hemochromatosis, serum biomarkers, erythropoiesis
MeSH terms
Anemia, Dyserythropoietic, Congenital, Erythropoiesis, Female, Ferritins, Humans, Iron, Israel, Male, Biomarkers, Case-Control Studies, Iron Overload, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review